Volume 90 Issue 21 | p. 19 | Concentrates
Issue Date: May 21, 2012

Bristol-Myers Joins With Tsinghua

Department: Business
Keywords: oncology, target identification, China

In its first drug discovery collaboration in China, Bristol-Myers Squibb will fund research at Tsinghua University’s School of Life Sciences, in Beijing. In an effort spanning several years, Tsinghua will work on behalf of BMS to identify and validate new targets in oncology and immunoscience. The two will also work together in structural biology and mapping the three-dimensional structure of protein targets.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment